EU: BioNTech-Pfizer needs to adapt its vaccine against variants in 100 days

Answering the question about the Omikron variant, which was first detected in South Africa, at the press conference held during his visit to Latvia, von der Leyen said that the variant is worrying.


“Scientists and pharmaceutical companies need 2-3 weeks to see the full picture about the Omicron variant,” von der Leyen said. said.

Emphasizing that this period should be used to increase vaccinations and booster doses, von der Leyen said that the contracts signed between vaccine companies and the EU also contain clauses for the development of vaccines against possible variants.


Von der Leyen said, “This summer, the EU Commission signed a contract with BioNTech-Pfizer for the third time. This included the purchase of 1.8 billion doses of vaccine. This order has been placed. There are also options we can use. There is also a certain clause in the contract. This is a tough variant. He states that if it does occur, BioNTech-Pfizer must adapt its vaccine within 100 days.” used the phrase.

EU countries stopped flights to Europe from many African countries after the Omikron variant was detected. (AA)